318 related articles for article (PubMed ID: 24684459)
1. The impact of obesity on the presentation of primary hyperparathyroidism.
Tran H; Grange JS; Adams-Huet B; Nwariaku FE; Rabaglia JL; Woodruff SL; Holt SA; Maalouf NM
J Clin Endocrinol Metab; 2014 Jul; 99(7):2359-64. PubMed ID: 24684459
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in the presentation, course and outcomes of primary hyperparathyroidism.
Dadon T; Tsvetov G; Levi S; Gorshtein A; Slutzky-Shraga I; Hirsch D
Maturitas; 2021 Mar; 145():12-17. PubMed ID: 33541557
[TBL] [Abstract][Full Text] [Related]
3. Normocalcaemic primary hyperparathyroidism: is nephrolithiasis more common than osteoporosis?
Wu KCJ; Anpalahan M
Intern Med J; 2023 Jan; 53(1):112-118. PubMed ID: 34435736
[TBL] [Abstract][Full Text] [Related]
4. Hypomagnesuria is Associated With Nephrolithiasis in Patients With Asymptomatic Primary Hyperparathyroidism.
Saponaro F; Marcocci C; Apicella M; Mazoni L; Borsari S; Pardi E; Di Giulio M; Carlucci F; Scalese M; Bilezikian JP; Cetani F
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32369583
[TBL] [Abstract][Full Text] [Related]
5. Sporadic primary hyperparathyroidism and stone disease: a comprehensive metabolic evaluation before and after parathyroidectomy.
Marchini GS; Faria KVM; Torricelli FCM; Monga M; Srougi M; Nahas WC; Mazzucchi E
BJU Int; 2018 Feb; 121(2):281-288. PubMed ID: 29124877
[TBL] [Abstract][Full Text] [Related]
6. Current opinions on nephrolithiasis associated with primary hyperparathyroidism.
Cong X; Shen L; Gu X
Urolithiasis; 2018 Oct; 46(5):453-457. PubMed ID: 29350243
[TBL] [Abstract][Full Text] [Related]
7. Association between hypomagnesemia and severity of primary hyperparathyroidism: a retrospective study.
Na D; Tao G; Shu-Ying L; Qin-Yi W; Xiao-Li Q; Yong-Fang L; Yang-Na O; Zhi-Feng S; Yan-Yi Y
BMC Endocr Disord; 2021 Aug; 21(1):170. PubMed ID: 34416890
[TBL] [Abstract][Full Text] [Related]
8. Persistently Elevated PTH After Parathyroidectomy at One Year: Experience in a Tertiary Referral Center.
Caldwell M; Laux J; Clark M; Kim L; Rubin J
J Clin Endocrinol Metab; 2019 Oct; 104(10):4473-4480. PubMed ID: 31188435
[TBL] [Abstract][Full Text] [Related]
9. The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism.
Düğer H; Bostan H; Gül Ü; Uçan B; Hepşen S; Sakız D; Akhanlı P; Çakal E; Kızılgül M
J Endocrinol Invest; 2023 Sep; 46(9):1935-1940. PubMed ID: 36929458
[TBL] [Abstract][Full Text] [Related]
10. Does renal function improve after parathyroidectomy in primary hyperparathyroidism?
García-Martín F; Guadalix S; García-Boyano F; Melón Peña N; Martínez Pueyo JI; Callejas Martínez R; Praga Terente M
Nefrologia (Engl Ed); 2019; 39(2):160-167. PubMed ID: 30459009
[TBL] [Abstract][Full Text] [Related]
11. What Predicts Recurrent Kidney Stone after Parathyroidectomy in Patients with Primary Hyperparathyroidism?
Islam AK; Holt S; Reisch J; Nwariaku F; Antonelli J; Maalouf NM
J Am Coll Surg; 2020 Jul; 231(1):74-82. PubMed ID: 32330575
[TBL] [Abstract][Full Text] [Related]
12. Influence of age and gender on presentation of symptomatic primary hyperparathyroidism.
Shah VN; Bhadada SK; Bhansali A; Behera A; Mittal BR; Bhavin V
J Postgrad Med; 2012; 58(2):107-11. PubMed ID: 22718053
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Nephrolithiasis, Osteoporosis, and Mortality in Primary Hyperparathyroidism.
Reid LJ; Muthukrishnan B; Patel D; Seckl JR; Gibb FW
J Clin Endocrinol Metab; 2019 Sep; 104(9):3692-3700. PubMed ID: 30916764
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
Sho S; Kuo EJ; Chen AC; Li N; Yeh MW; Livhits MJ
Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
[TBL] [Abstract][Full Text] [Related]
15. Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa.
Govind K; Paruk IM; Motala AA
BMC Endocr Disord; 2024 Apr; 24(1):53. PubMed ID: 38664758
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of patients with mildly elevated parathormone and calcium levels.
Parikh PP; Allan BJ; Lew JI
World J Surg; 2014 Jun; 38(6):1289-95. PubMed ID: 24615605
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China.
Lin X; Fan Y; Zhang Z; Yue H
Front Endocrinol (Lausanne); 2021; 12():602221. PubMed ID: 33716964
[TBL] [Abstract][Full Text] [Related]
18. Evaluation for Primary Hyperparathyroidism in Patients Who Present With Nephrolithiasis.
Behrens M; Boyle S; Fingeret AL
J Surg Res; 2021 Jan; 257():79-84. PubMed ID: 32818787
[TBL] [Abstract][Full Text] [Related]
19. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
Lowe H; McMahon DJ; Rubin MR; Bilezikian JP; Silverberg SJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
